Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).
Authors
Dearnaley, DSyndikus, I
Mossop, H
Birtle, A
Bloomfield, D
Cruickshank, C
Graham, J
Hasan, S
Khoo, V
Logue, John P
Mayles, H
Money-Kyrle, J
Naismith, O
Panades, M
Patterson, H
Scrase, C
Staffurth, J
Tremlett, J
Griffin, C
Hall, E
Affiliation
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, LondonIssue Date
2016